Editorial
doi: 10.1093/cid/ciy421.
Mycoplasma pneumoniae as a Cause of Community-Acquired Pneumonia in Children
Affiliations
- PMID: 29788200
- DOI: 10.1093/cid/ciy421
Item in Clipboard
Editorial
Mycoplasma pneumoniae as a Cause of Community-Acquired Pneumonia in Children
Clin Infect Dis.
.
No abstract available
Comment on
-
Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia.Clin Infect Dis. 2019 Jan 1;68(1):5-12. doi: 10.1093/cid/ciy419. Clin Infect Dis. 2019. PMID: 29788037 Free PMC article.
Similar articles
-
Diagnosis and treatment of Mycoplasma pneumoniae in children.Minerva Pediatr. 2017 Apr;69(2):156-160. doi: 10.23736/S0026-4946.16.04866-0. Minerva Pediatr. 2017. PMID: 28178776 Review.
-
Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.Ital J Pediatr. 2014 Dec 18;40:104. doi: 10.1186/s13052-014-0104-4. Ital J Pediatr. 2014. PMID: 25518734 Free PMC article.
-
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents.Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):742-5. doi: 10.1007/s10096-003-1037-9. Epub 2003 Nov 11. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14610659
-
Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.Pediatr Infect Dis J. 2013 Dec;32(12):1396-9. doi: 10.1097/INF.0b013e3182a25c71. Pediatr Infect Dis J. 2013. PMID: 23817339
-
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.Cochrane Database Syst Rev. 2010 Jul 7;(7):CD004875. doi: 10.1002/14651858.CD004875.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004875. doi: 10.1002/14651858.CD004875.pub4 PMID: 20614439 Updated. Review.
Cited by
-
An exceptionally large wave of M. pneumoniae infections among children in Tianjin post COVID-19 pandemic.Transl Pediatr. 2024 Oct 1;13(10):1703-1710. doi: 10.21037/tp-24-228. Epub 2024 Oct 28. Transl Pediatr. 2024. PMID: 39524400 Free PMC article.
-
The efficacy of azithromycin combined with seven types of Chinese medicine injections in the treatment of Mycoplasma pneumoniae pneumonia in children: a systematic review and Bayesian network meta-analysis.Front Pharmacol. 2024 Sep 24;15:1378445. doi: 10.3389/fphar.2024.1378445. eCollection 2024. Front Pharmacol. 2024. PMID: 39421669 Free PMC article.
-
Efficacy and safety of Lianhua Qingwen granule combined with azithromycin for mycoplasma pneumoniae pneumonia in children: a systematic review with meta-analysis and trial sequential analysis.Front Pharmacol. 2024 Jun 27;15:1374607. doi: 10.3389/fphar.2024.1374607. eCollection 2024. Front Pharmacol. 2024. PMID: 38994206 Free PMC article.
-
Atypical bacterial respiratory infections in children.J Bras Pneumol. 2024 May 27;50(2):e20240126. doi: 10.36416/1806-3756/e20240126. J Bras Pneumol. 2024. PMID: 38808838 Free PMC article. No abstract available.
-
Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019.Epidemiol Infect. 2024 Apr 18;152:e75. doi: 10.1017/S0950268824000323. Epidemiol Infect. 2024. PMID: 38634450 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
